What is TrialNet?
TrialNet is an international network of sites throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia, and New Zealand. This network is dedicated to the study, prevention, and early treatment of type 1 diabetes.There will be two types of studies:
- Natural History Studies which will provide information about risk factors associated with developing type 1 diabetes.
- Diabetes Intervention Studies which will test either treatments to delay or prevent the onset of type 1 diabetes, or test treatments to preserve remaining insulin secretion in people recently diagnosed with type 1 diabetes.
TrialNet is supported by the United States National Institutes of Health and Department of Health & Human Services, Juvenile Diabetes Research Foundation International, and the American Diabetes Association.